Tandem Diabetes Care Inc’s recent filing unveils that its Director Allen Dick acquired Company’s shares for reported $94778.0 on Nov 27 ’23. In the deal valued at $18.96 per share,5,000 shares were bought. As a result of this transaction, Allen Dick now holds 19,962 shares worth roughly $0.6 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Vosseller Leigh bought 6,200 shares, generating $95,395 in total proceeds. Upon buying the shares at $15.39, the EVP & CHIEF FINANCIAL OFFICER now owns 11,860 shares.
Before that, Hansen Shannon Marie bought 1,935 shares. Tandem Diabetes Care Inc shares valued at $29,884 were divested by the Chief Legal Officer at a price of $15.44 per share. As a result of the transaction, Hansen Shannon Marie now holds 1,935 shares, worth roughly $58243.5.
Citigroup downgraded its Tandem Diabetes Care Inc [TNDM] rating to a Neutral from a a Buy in a research note published on August 04, 2023; the price target was decreased to $33 from $45. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early May from “a Neutral” to “an Underperform”. Raymond James also remained covering TNDM and has decreased its forecast on April 24, 2023 with a “Mkt perform” recommendation from previously “an Outperform” rating. UBS started covering the stock on March 29, 2023. It rated TNDM as “a Neutral”.
Price Performance Review of TNDM
On Monday, Tandem Diabetes Care Inc [NASDAQ:TNDM] saw its stock fall -0.53% to $30.10. Over the last five days, the stock has lost -3.28%. Tandem Diabetes Care Inc shares have risen nearly 1.76% since the year began. Nevertheless, the stocks have fallen -27.87% over the past one year. While a 52-week high of $43.51 was reached on 03/21/24, a 52-week low of $13.82 was recorded on 01/31/24. SMA at 50 days reached $26.18, while 200 days put it at $24.91. A total of 1.17 million shares were traded, compared to the trading of 1.76 million shares in the previous session.
Levels Of Support And Resistance For TNDM Stock
The 24-hour chart illustrates a support level at 29.59, which if violated will result in even more drops to 29.07. On the upside, there is a resistance level at 30.93. A further resistance level may holdings at 31.75. The Relative Strength Index (RSI) on the 14-day chart is 55.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.80%. Stochastics %K at 62.23% indicates the stock is a holding.
How much short interest is there in Tandem Diabetes Care Inc?
A steep rise in short interest was recorded in Tandem Diabetes Care Inc stocks on Feb 29, 2024, dropping by -0.53 million shares to a total of 4.9 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 5.43 million shares. There was a decline of -10.82%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 8.35% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.04.
The most recent change occurred on January 26, 2023 when Wolfe Research began covering the stock and recommended ‘”a Peer perform”‘ rating.
